UK's Hargreaves says Dechra's Platt to succeed Oppenheimer as chair

Dechra Pharmaceuticals

29/11/2023 07:15

Nov 29 (Reuters) - British investment platform
Hargreaves Lansdown  HRGV.L  on Wednesday appointed Alison Platt
as chair to succeed Deanna Oppenheimer, who will step down at
the company's annual general meeting after six years in the
role.
    Platt is currently chair of veterinary pharmaceuticals maker
Dechra Pharmaceuticals  DPH.L , which is being bought by Swedish
private equity firm EQT  EQTAB.ST  for 4.46 billion pounds 
($5.66 billion).  

($1 = 0.7874 pounds)

 (Reporting by Yadarisa Shabong in Bengaluru; Editing by Sonia
Cheema)
 ((Yadarisa.Shabong@thomsonreuters.com; +91 9742735150;))